KISS1R and metabolic dysfunction-associated steatotic liver disease: Taken together, this suggests that KP critically exerts its protective effect in vivo under pathophysiological conditions by activating hepatic KISS1R to downregulate lipid synthesis via AMPK activation as well as increasing β-oxidation, thus attenuating the development of NAFLD.